Assessment of cognitive functions in animal models of schizophrenia

被引:0
|
作者
Agnieszka Nikiforuk
机构
[1] Institute of Pharmacology,Department of Behavioral Neuroscience and Drug Development
[2] Polish Academy of Sciences,undefined
来源
Pharmacological Reports | 2018年 / 70卷
关键词
Cognition; Schizophrenia; Translation; Neurocognitive tests; Rodent models;
D O I
暂无
中图分类号
学科分类号
摘要
Impaired cognitive functioning is recognized as an integral feature of schizophrenia. These deficits have emerged not only as an important predictor of clinical and social outcomes but also as a target for schizophrenia therapeutics. Several cognitive functions have been identified as being commonly deficient in schizophrenia patients, including attention, working memory, reasoning and problem solving, visual learning and memory or social cognition. The selected neuropsychological tests measuring these specific domains were included in the MATRICS Consensus Cognitive Battery (MCCB) and in the Cambridge Neuropsychological Test Automated Battery (CANTAB). While the MCCB and the CANTAB are used in clinical trials of cognition-enhancing drugs for schizophrenia, there is a growing need for a translational test battery that can be used in animal models. To reduce the translational gap between preclinical and clinical studies, the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CINTRICS) programme has recommended animal tasks with construct validity for the evaluation of cognitive domains that are affected in schizophrenia. This review will overview rodent tests that are widely used to identify schizophrenia-like cognitive impairments, including CINTRICS’s recommendations and novel touchscreen-based procedures.
引用
收藏
页码:639 / 649
页数:10
相关论文
共 50 条
  • [21] Overview on animal models of schizophrenia
    Geyer, M. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S199 - S199
  • [22] Development of animal models for schizophrenia
    Arguello, P. Alexander
    Markx, Sander
    Gogos, Joseph A.
    Karayiorgou, Maria
    DISEASE MODELS & MECHANISMS, 2010, 3 (1-2) : 22 - 26
  • [23] Animal Models of Relevance to the Schizophrenia
    Petty, Alice
    Howes, Oliver
    Eyles, Darryl
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (01): : 22 - 32
  • [24] Pathophysiology and Animal Models of Schizophrenia
    Dawe, Gavin S.
    Hwang, Ern Huei Joel
    Tan, Chay Hoon
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2009, 38 (05) : 425 - 430
  • [25] Glutamatergic animal models of schizophrenia
    Moghaddam, B
    Jackson, ME
    GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 : 131 - 137
  • [26] Pharmacogenomics and animal models of schizophrenia
    Klink, R
    Boksa, P
    Joober, R
    DRUG DEVELOPMENT RESEARCH, 2003, 60 (02) : 95 - 103
  • [27] Glutamatergic Animal Models of Schizophrenia
    Bondi, Corina
    Matthews, Marguerite
    Moghaddam, Bita
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (12) : 1593 - 1604
  • [28] Associated impairments of neural coordination and cognitive control in schizophrenia-related animal models
    Fenton, Andre Antonio
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 137S - 137S
  • [29] Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
    Neill, Joanna C.
    Barnes, Samuel
    Cook, Samantha
    Grayson, Ben
    Idris, Nagi F.
    McLean, Samantha L.
    Snigdha, Shikha
    Rajagopal, Lakshmi
    Harte, Michael K.
    PHARMACOLOGY & THERAPEUTICS, 2010, 128 (03) : 419 - 432
  • [30] Cellular repair of striatal motor and cognitive functions in animal models of Huntington disease
    Dunnett, S. B.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 537 - 537